Parkinsonian Sutter
Stimulation of the Thalamus to Ameliorate Parkinsonian Speech Disfluencies: Pilot Study
1 other identifier
interventional
3
0 countries
N/A
Brief Summary
The research team aims to provide evidence of Parkinsonian (PD) Stutter management by addressing the primary neurological issue in this disorder using Deep Brain Stimulation (DBS). The team proposes to perform unilateral DBS on 3 patients with PD stutter refractory to intensive speech therapy, to determine a response in their PD stutter. The assessments will be double-blinded. The investigators will use the outcome of this case series to determine the feasibility and details of a larger randomized controlled trial.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Dec 2023
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
October 10, 2023
CompletedFirst Posted
Study publicly available on registry
October 23, 2023
CompletedStudy Start
First participant enrolled
December 1, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2024
CompletedOctober 23, 2023
October 1, 2023
1 year
October 10, 2023
October 16, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Change of One-Page Suttering Assessment from Baseline to Post-Operation
Objectively assesses individual's stutter. Divide the number of instances of stuttering by the number of syllables in the sample and multiply by 100 to obtain the percentage of stuttered syllables.
One-Page Stutter Assessment will be reported by the patients preoperatively, after three months of blinded DBS-ON and DBS-OFF, and then again after 6 months unblinded DBS-ON
Secondary Outcomes (2)
Change of Voice Related Quality of Life (VRQoL) from Baseline to Post-Operation
V-RQOL will be reported by the patients preoperatively, after three months of blinded DBS-ON and DBS-OFF, and then again after 6 months unblinded DBS-ON
Change of Overall Assessment of the Speaker's Experience of Stuttering (OASES) from Baseline to Post-Operation
OASES will be reported by the patients preoperatively, after three months of blinded DBS-ON and DBS-OFF, and then again after 6 months unblinded DBS-ON
Study Arms (1)
Deep Brain Simulation (DBS) System
EXPERIMENTALThe DBS device will be turned on to compare stutter to when the device was off (which would be the control).
Interventions
The DBS system will be turned on, and the individual's stutter will be assessed.
The DBS system will be turned off, and the individual's stutter will be assessed.
Eligibility Criteria
You may qualify if:
- Adults between the ages of 19 and 80 years old
- Individuals with persistent PD stutter
You may not qualify if:
- Patients with mild symptoms.
- Patients who have a neurodegenerative disease.
- Patients with a bleeding diathesis.
- non English speaking patients
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor of Neurosurgery
Study Record Dates
First Submitted
October 10, 2023
First Posted
October 23, 2023
Study Start
December 1, 2023
Primary Completion
December 1, 2024
Study Completion
December 1, 2024
Last Updated
October 23, 2023
Record last verified: 2023-10